Clinical Trial Update: Amlodipine as Adjuvant Treatment to Iron Chelation for Prevention of Cardiac Iron Overload in Thalassemia Patients [NA]

View source ↗

Summary

This document reports a clinical trial evaluating amlodipine as an adjuvant to iron chelation to prevent cardiac iron overload in beta-thalassemia patients. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia
• Iron Overload

Drugs mentioned

• NORVASC (amlodipine besylate)

Snippet

Sponsor: Kevin H.M. Kuo, MD, MSc, FRCPC | Conditions: Beta-Thalassemia, Iron Overload | NA | Status: UNKNOWN